🇭🇺 Country Profile

Hungary

Affordable medicine reaching Hungary

🇭🇺 $97.1M

Dual-source profile. Both series show HS Chapter 30 (finished pharmaceutical products) aligned to calendar year (Jan–Dec). Eurostat records what Hungary imports from India. DGCIS records what India exports to Hungary. Category and product detail from DGCIS.

$97.1M

Scale

Hungary's patients receive $97.1M in Indian pharmaceutical products annually — almost entirely finished medicines ready for dispensing.

84%

Medicine

Overwhelmingly finished medicines — drug formulations account for 84% of shipments.

1.3×

Trajectory

Steady growth: Hungary imported $97.1M in Indian pharmaceutical products in 2025, up from $75.2M in 2014.

Context

Part of India's pharmaceutical supply network across Europe.

✦

Impact

Indian pharmaceutical companies have both exported to and invested directly in Hungary — building trade and operational presence.

Non-Chapter-30 pharma categories from DGCIS (487-code basket)

Medicines $95.2M (83.6%) Medicine Ingredients $16.8M (14.8%) Surgical & Hospital Supplies $0.69M (0.6%) Traditional & Herbal $0.59M (0.5%) Vaccines $0.51M (0.4%)

Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $17.4M in active pharmaceutical ingredients and bulk drugs to Hungary in 2025 (India-reported, DGCIS).

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Hungary: $11.2M across 5 filings (2023-2026).